Corrigendum: Thyrostimulin regulates osteoblastic bone formation during early skeletal development (Endocrinology (2015) 156:9 (3098-3113) DOI: 10.1210/en.2014-1943);Thyrostimulin regulates osteoblastic bone formation during early skeletal development

Endocrinology

Volumn 156, Issue 9, 2015, Pages 3098-3113

  Bassett, J H Duncan ^a   Van Der Spek, Anne ^b   Logan, John G ^a   Gogakos, Apostolos ^a   Bagchi Chakraborty, Jayashree ^a   Murphy, Elaine ^a   Van Zeijl, Clementine ^b   Down, Jenny ^c   Croucher, Peter I ^c   Boyde, Alan ^d   Boelen, Anita ^b   Williams, Graham R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLYCOPROTEIN; GLYCOPROTEIN HORMONE SUBUNIT ALPHA 2; GLYCOPROTEIN HORMONE SUBUNIT BETA 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; THYROID HORMONE; THYROTROPIN; UNCLASSIFIED DRUG; THYROTROPIN RECEPTOR;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW STROMA CELL; BONE MASS; BONE MINERAL; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETON; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; ANIMAL; BONE; BONE DENSITY; BONE DEVELOPMENT; C57BL MOUSE; CHO CELL LINE; CRICETULUS; HAMSTER; KNOCKOUT MOUSE; METABOLISM; PARACRINE SIGNALING; PHENOTYPE;

ANIMALS; BONE AND BONES; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PARACRINE COMMUNICATION; PHENOTYPE; RECEPTORS, THYROTROPIN; THYROTROPIN;

EID: 84942769687     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2018-00190     Document Type: Erratum

References (49)

1. Nakabayashi K, Matsumi H, Bhalla A., et al. Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest. 2002; 109(11):1445-1452.
2. Hsu SY. New insights into the evolution of the relaxin-LGR signaling system. Trends Endocrinol Metab. 2003; 14(7):303-309.
3. Park JI, Semyonov J, Chang C.L., Hsu SY. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signaling system from nematodes to humans. Endocrine.2005; 26(3):267-276.
4. Okada SL, Ellsworth JL, Durnam D.M., et al. A glycoprotein hormone expressed in corticotrophs exhibits unique binding properties on thyroid-stimulating hormone receptor. Mol Endocrinol. 2006; 20(2):414-425.
5. Dos Santos S., Bardet C, Bertrand S., Escriva H, Habert D, Querat B. Distinct expression patterns of glycoprotein hormone-α2 and - β5 in a basal chordate suggest independent developmental functions. Endocrinology. 2009; 150(8):3815-3822.
6. Okajima Y, Nagasaki H, Suzuki C., et al. Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits α 2 (GPA2) and β 5 (GPB5). Regul Pept. 2008; 148(1-3):62-67.
7. Hsu SY, Nakabayashi K, Bhalla A. Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5. Mol Endocrinol. 2002; 16(7):1538-1551.
8. Donda A, Reymond F, Rey F., Lemarchand-Beraud T. Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat. Acta Endocrinol (Copenh). 1990; 122(5):577-584.
9. Sudo S, Kuwabara Y, Park J.I., Hsu SY, Hsueh AJ. Heterodimeric fly glycoprotein hormone-α2 (GPA2) and glycoprotein hormone-β5 (GPB5) activate fly leucine-rich repeat-containing G protein-coupled receptor-1 (DLGR1) and stimulation of human thyrotropin receptors by chimeric fly GPA2 and human GPB5. Endocrinology. 2005; 146(8):3596-3604.
10. Uchida K, Moriyama S, Chiba H., et al. Evolutionary origin of a functional gonadotropin in the pituitary of the most primitive vertebrate, hagfish. Proc Natl Acad Sci USA. 2010; 107(36):15832-15837.
11. Dos Santos S., Mazan S, Venkatesh B., Cohen-Tannoudji J, Querat B. Emergence and evolution of the glycoprotein hormone and neurotrophin gene families in vertebrates. BMC Evol Biol. 2011; 11: 332.
12. Lantz M, Vondrichova T, Capretz A., et al. Thyrostimulin (a TSH-like hormone) expression in orbital and thyroid tissue. Thyroid. 2007; 17(2):113-118.
13. Li C, Hirooka Y, Habu S., Takagi J, Gotoh M, Nogimori T. Distribution of thyrostimulin in the rat: an immunohisto chemical study. Endocr Regul. 2004; 38(4):131-142.
14. Nagasaki H, Wang Z, Jackson V.R., Lin S., Nothacker HP, Civelli O. Differential expression of the thyrostimulin subunits, glycoprotein α2 and β5 in the rat pituitary. J Mol Endocrinol. 2006; 37(1):39-50.
15. Oishi A, Gengyo-Ando K, Mitani S., et al. FLR-2, the glycoprotein hormone α subunit, is involved in the neural control of intestinal functions in Caenorhabditis elegans. Genes Cells. 2009; 14(10): 1141-1154.
16. Sellami A, Agricola HJ, Veenstra JA Neuroendocrine cells in Drosophila melanogaster producing GPA2/GPB5, a hormone with homology to LH, FSH and TSH. Gen Comp Endocrinol. 2011; 170(3): 582-588.
17. van Zeijl C.J., Surovtseva OV, Wiersinga W.M., Boelen A., Fliers E. Transient hypothyroxinemia in juvenile glycoprotein hormone subunit B5 knock-out mice. Mol Cell Endocrinol. 2010; 321(2):231-238.
18. Alvarez E, Cahoreau C, Combarnous Y. Comparative structure analyses of cystine knot-containing molecules with eight aminoacyl ring including glycoprotein hormones (GPH) α and β subunits and GPH-related A2 (GPA2) and B5 (GPB5) molecules. Reprod Biol Endocrinol. 2009; 7:90.
19. Sun SC, Hsu PJ, Wu F.J., Li SH, Lu CH, Luo CW. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. J Biol Chem. 2010; 285(6):3758-3765.
20. Bodó E, Kany B, Gáspár E, et al. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010; 151(4):1633-1642.
21. Macdonald LE, Wortley KE, Gowen L.C., et al. Resistance to dietinduced obesity in mice globally overexpressing OGH/GPB5. Proc Natl Acad Sci USA. 2005; 102(7):2496-2501.
22. Inoue M, Tawata M, Yokomori N., Endo T, Onaya T. Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells. Thyroid. 1998; 8(11):1059-1064.
23. Abe E, Marians RC, Yu W, et al TSH is a negative regulator of skeletal remodeling. Cell. 2003; 115(2):151-162.
24. Bassett JH, Williams AJ, Murphy E, et al A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol. 2008; 22(2):501-512.
25. O'Shea P.J., Kim DW, Logan J.G., et al. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J Biol Chem. 2012; 287(21):17812-17822.
26. Williams AJ, Robson H, Kester M.H., et al. Iodothyronine deiodinase enzyme activities in bone. Bone. 2008; 43(1):126-134.
27. Rauner M, Föger-Samwald U, Kurz MF, et al. Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture. Bone. 2014; 64:281-287.
28. Ludgate M, Costagliola S, Danguy D., Perret J, Vassart G. Recombinant TSH-receptor for determination of TSH-receptor-antibodies. Exp Clin Endocrinol. 1992; 100(1-2):73-74.
29. Hernandez A, Martinez ME, Liao X.H., et al. Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology. 2007; 148(12):5680-5687.
30. Bassett JH, Boyde A, Howell P.G., et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA. 2010; 107(16):7604-7609.
31. Bassett JH, van der Spek A, Gogakos A, Williams GR. Quantitative X-ray imaging of rodent bone by Faxitron. Methods Mol Biol. 2012; 816:499-506.
32. Bassett JH, Gogakos A, White J.K., et al. Rapid-throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes that determine bone strength. PLoS Genet. 2012; 8(8):e1002858.
33. Bouxsein ML, Boyd SK, Christiansen B.A., Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 25(7): 1468-1486.
34. Bassett JH, Nordström K, Boyde A., et al. Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol. 2007; 21(8):1893-1904.
35. Dempster DW, Compston JE, Drezner M.K., et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013; 28(1):2-17.
36. Gogakos A, Logan JG, Waung J.A., et al. THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women. Eur J Endocrinol. 2014; 170(4):637-644.
37. Bassett JH, O'Shea PJ, Sriskantharajah S, et al Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol. 2007; 21(5):1095-1107.
38. Vincent BH, Montufar-Solis D, Teng B.B., Amendt BA, Schaefer J, Klein JR. Bone marrow cells produce a novel TSHβ splice variant that is upregulated in the thyroid following systemic virus infection. Genes Immun. 2009; 10(1):18-26.
39. Baliram R, Sun L, Cao J., et al. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest. 2012; 122(10):3737-3741.
40. Baliram R, Chow A, Huber A.K., et al. Thyroid and bone: macrophage-derived TSH-β-splice variant increases murine osteoblastogenesis. Endocrinology. 2013; 154(12):4919-4926.
41. Schaefer JS, Klein JR A novel thyroid stimulating hormone β-subunit isoform in human pituitary, peripheral blood leukocytes, and thyroid. Gen Comp Endocrinol. 2009; 162(3):241-244.
42. O'Shea P.J., Bassett JHD, Cheng SY, Williams GR Characterization of skeletal phenotypes of TRα1PV and TRβPV mutant mice: implications for tissue thyroid status and T3 target gene expression. Nuc Rec Signal. 2006; 4:e011.
43. Stevens DA, Hasserjian RP, Robson H, Siebler T., Shalet SM, Williams GR. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res. 2000; 15(12):2431-2442.
44. Hase H, Ando T, Eldeiry L., et al. TNF α mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci USA. 2006; 103(34):12849-12854.
45. Arufe MC, Lu M, Kubo A., Keller G, Davies TF, Lin RY Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology. 2006; 147(6):3007-3015.
46. Bagriacik EU, Yaman M, Haznedar R., Sucak G, Delibasi T. TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells. J Endocrinol. 2012; 212(2):169-178.
47. Bell A, Gagnon A, Dods P., Papineau D, Tiberi M, Sorisky A. TSH signaling and cell survival in 3T3-L1 preadipocytes. Am J Physiol Cell Physiol. 2002; 283(4):C1056-C1064.
48. Lin RY, Kubo A, Keller G.M., Davies TF. Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology. 2003; 144(6):2644-2649.
49. Lu M, Lin RY TSH stimulates adipogenesis in mouse embryonic stem cells. J Endocrinol. 2008; 196(1):159-169.